Your browser doesn't support javascript.
loading
Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.
Amano, Tomokazu; Yu, Hong; Amano, Misa; Leyder, Erica; Badiola, Maria; Ray, Priyanka; Kim, Jiyoung; Ko, Akihiro C; Achour, Achouak; Weng, Nan-Ping; Kochba, Efrat; Levin, Yotam; Ko, Minoru S H.
Affiliation
  • Amano T; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
  • Yu H; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
  • Amano M; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
  • Leyder E; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
  • Badiola M; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
  • Ray P; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
  • Kim J; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
  • Ko AC; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
  • Achour A; Laboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD, USA.
  • Weng NP; Laboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD, USA.
  • Kochba E; NanoPass Technologies Ltd., Ness Ziona, Israel.
  • Levin Y; NanoPass Technologies Ltd., Ness Ziona, Israel.
  • Ko MSH; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
iScience ; 26(4): 106335, 2023 Apr 21.
Article in En | MEDLINE | ID: mdl-36968065

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IScience Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IScience Year: 2023 Type: Article Affiliation country: United States